Capretz & Associates

(800) 351-8588

5000 Birch St., Suite 4600
Newport Beach, CA 92660
Directions

Product Liability
individual and class
action lawsuits

Ethex Morphine Sulfate Tablet Recall

On June 13, 2008 Ethex Corporation recalled specific lots of its Morphine Sulfate Tablets. The recall covers specific lots of morphine sulfate 60 mg extended release tablets, and specific lots of morphine sulfate 30 mg extended release tablets, due to the possible presence of oversized tablets. Oversized tablets may contain as much as two times the labeled level of active morphine sulfate. The recalled lots were distributed under an “ETHEX” label between June 2006 and May 2008.

The lot numbers involved in the recall are:

Morphine Sulfate ER 30mg Tablet/NDC # 58177-320-04: Lots 75090, 77846, 77847, 80048, 83320, 89661, 89665, 90252 through 90258, and 93284

Morphine Sulfate ER 60mg Tablet/NDC # 58177-330-04: Lots 91762 (previously reported), 75091, 75092, 77848 through 77851, 82517, 82518, 83333, 83817, 83862, 84111, 84112, 84315, 84900, 85326, 85335, 85807, 86270 through 86276, 87723, 87939, 88007, 89083, 89668, 89669, 89821, 90260 through 90272, and 91763 through 91765.

The 60 mg product is a white oval tablet with “60” on one side, and “E” on the reverse. The 30 mg product is a pink oval tablet with “30” on one side, and “E” on the reverse.

If you believe you have these recalled tablets, we recommend you call your physician, pharmacist or other health care provider.

If you believe you may have been injured after ingesting tablets from any of the above-listed recalled lot numbers, you may contact our office for a free consultation. Call (800) 351-8588 or e-mail us by clicking here.

Click here to see the FDA Recall Notice

Share This Page:
Designed and Powered by NextClient

© 2014 - 2017 Capretz & Associates. All rights reserved.
Theme WebExpress™ attorney website design by NextClient.com.

Contact Form Tab